Questions? Feedback? powered by Olark live chat software
All Site

In Vitro Technologies announces a new partnership with Advanced Cell Diagnostics Inc.

Gene Expression Analysis by RNA In Situ Hybridization
Any Gene – Any Species – Any Tissue

We are very pleased to announce that Advanced Cell Diagnostics (ACD) Inc. has appointed In Vitro Technologies as their new exclusive distributor in Australia and New Zealand.

Known as "the company that revolutionized RNA ISH", Advanced Cell Diagnostics Inc. is a leader in the emerging field of molecular pathology, developing cell and tissue-based diagnostic tests for personalized medicine. Advanced Cell Diagnostics RNAscope® technology is the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity. 

Introducing ACD and RNAscope ISH:

1 Day assay-- The easy IHC-like protocol means you can get same-day results. This robust, versatile and fast solution have been applied to a wide range of applications in the fields of Cancer, Neuroscience, Infectious diseases, Inflammation and Stem Cells. 
500 Publications-- The ACD research install base has experienced massive success, measured via peer-reviewed publications. With 500+ publications, 204 of which from 2015 alone, ACD customers are succeeding with about 25 new publications per month.
140 Species-- RNAscope ISH can be applied to interrogate virtually any gene, in any species in any tissue, so if your research is challenged by antibody availability, RNAscope can advance your projects. The assay has been applied to samples from over 140 species.
>30,000 Targets available-- Researchers have ordered 30,000+ targets in 140+ species. If probes for your target gene of interest is not available from the catalogue, ACD can produce new gene specific probes in just 2 weeks.

 

The addition of Advanced Cell Diagnostics RNAscope technology to our existing portfolio of premium brands, we are now, more than ever in a position to aid in accelerating discovery through high quality, reproducible data for In Situ Hybridization and Immunohistochemistry applications.

For all technical enquiries or for further information on the RNA In Situ Hybridization and Immunohistochemistry solutions from In Vitro Technologies, please contact your local In Vitro Technologies Territory Manager or our Life Science Support team at lifesicence@invitro.com.au

Together, both ACD and In Vitro Technologies look forward to providing our customers with premium products and technical support for all your RNA In Situ Hybridization assays.

In Vitro Technologies: Accelerating Discovery.

02.02.2017